Multiparametric flow cytometry measurable residual disease monitoring provides clinical relevance in real-world adult acute myeloid leukaemia patients

Key Points

• This research aims to validate a multiparametric flow cytometry assay for monitoring measurable residual disease in acute myeloid leukaemia patients.
• Assessed the effectiveness of a multiparametric flow cytometry MRD assay in a clinical setting.
• Focused on adult patients with acute myeloid leukaemia.
• Compared the results with traditional molecular methods.
• Multiparametric flow cytometry provided effective monitoring for measurable residual disease.
• Significant clinical relevance was observed in adult patients with acute myeloid leukaemia.